Merkel Cell Tumor. A Chemosensitive Skin Cancer
Authors
Affiliations
The clinical courses of six patients treated with cytotoxic chemotherapy for recurrent Merkel cell tumor of the skin are reported. All patients experienced prompt clinical responses to chemotherapy (five complete response [CR], one partial response [PR]) and three patients (50%) have achieved long-term disease-free remission. The report highlights (1) the aggressive nature of Merkel cell skin cancer, (2) the highly chemosensitive nature of the disease, and (3) some practical problems in administering chemotherapy to elderly patients.
Frequency and locations of systemic metastases in Merkel cell carcinoma by imaging.
Kouzmina M, Koljonen V, Leikola J, Bohling T, Lantto E Acta Radiol Open. 2017; 6(3):2058460117700449.
PMID: 28540062 PMC: 5433554. DOI: 10.1177/2058460117700449.
Nghiem P, Kaufman H, Bharmal M, Mahnke L, Phatak H, Becker J Future Oncol. 2017; 13(14):1263-1279.
PMID: 28350180 PMC: 6040046. DOI: 10.2217/fon-2017-0072.
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.
Miller N, Bhatia S, Parvathaneni U, Iyer J, Nghiem P Curr Treat Options Oncol. 2013; 14(2):249-63.
PMID: 23436166 PMC: 3651762. DOI: 10.1007/s11864-013-0225-9.
G3139 (Genasense) in patients with advanced merkel cell carcinoma.
Shah M, Varker K, Collamore M, Zwiebel J, Coit D, Kelsen D Am J Clin Oncol. 2009; 32(2):174-9.
PMID: 19307957 PMC: 4311264. DOI: 10.1097/COC.0b013e31817eebf8.
Primary neuroendocrine (merkel cell) carcinoma of the anterior skull base.
Matula C, Roessler K, Burian M, Schuster H, Trattnig S, Hainfellner J Skull Base Surg. 1997; 7(3):151-8.
PMID: 17171025 PMC: 1656637. DOI: 10.1055/s-2008-1058607.